BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
281 results:

  • 1. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms.
    Xie J; Wu D; Zhang P; Zhao S; Qi M
    Exp Dermatol; 2024 Apr; 33(4):e15070. PubMed ID: 38570935
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
    Jeong H; Cho YR; Gim J; Cha SK; Kim M; Kang DR
    PLoS One; 2024; 19(3):e0291223. PubMed ID: 38536842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma.
    Gong H; Liu Z; Yuan C; Luo Y; Chen Y; Zhang J; Cui Y; Zeng B; Liu J; Li H; Deng Z
    Comput Biol Med; 2024 Mar; 171():108198. PubMed ID: 38417385
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Post Renal Transplant Malignancies; A Basic Concept.
    Nabi Z; Zahid T; Nabi R
    J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The high expression of TOP2A and MELK induces the occurrence of psoriasis.
    Zhu X; Zhang E; Qin L
    Aging (Albany NY); 2024 Feb; 16(4):3185-3199. PubMed ID: 38382096
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Establishment of skin cutaneous melanoma prognosis model based on vascular mimicry risk score.
    Wang Y; Zou L; Song M; Zong J; Wang S; Meng L; Jia Z; Zhao L; Han X; Lu M
    Medicine (Baltimore); 2024 Feb; 103(7):e36679. PubMed ID: 38363903
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
    Wang J; Liu M; Sun J; Zhang Z
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
    Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
    Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
    Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An ensemble-based deep learning model for detection of mutation causing cutaneous melanoma.
    Ali Shah A; Shaker ASA; Jabbar S; Abbas Q; Al-Balawi TS; Celebi ME
    Sci Rep; 2023 Dec; 13(1):22251. PubMed ID: 38097641
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
    Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
    Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anoikis patterns via machine learning strategy and experimental verification exhibit distinct prognostic and immune landscapes in melanoma.
    Liu J; Ma R; Chen S; Lai Y; Liu G
    Clin Transl Oncol; 2024 May; 26(5):1170-1186. PubMed ID: 37989822
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Joint effect of RRP9 and DDX21 on development of colorectal cancer and keloid.
    Liu H; Chi X; Yang N; Shan M; Xiao Y; Zhang M; Hao Y; Hou S; Liu Y; Wang Y
    Aging (Albany NY); 2023 Nov; 15(24):14703-14719. PubMed ID: 37988222
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculator.
    McEvoy AM; Hippe DS; Lachance K; Park S; Cahill K; Redman M; Gooley T; Kattan MW; Nghiem P
    J Am Acad Dermatol; 2024 Mar; 90(3):569-576. PubMed ID: 37984720
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples.
    Huergo-Baños C; Velasco V; Garate J; Fernández R; Martín-Allende J; Zabalza I; Artola JL; Martí RM; Asumendi A; Astigarraga E; Barreda-Gómez G; Fresnedo O; Ochoa B; Boyano MD; Fernández JA
    Int J Cancer; 2024 Feb; 154(4):712-722. PubMed ID: 37984064
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.